Login
Microba Life Sciences lists on ASX
Gut health business Microba Life Sciences (ASX: MAP) has successfully listed on the Australian Securities Exchange, in an initial public offering that raised $30 million.
Jerome Doraisamy
Firm: Thomson Geer (Microba Life Sciences)
The IPO was backed by New York Stock Exchange-listed synthetic biology company Ginkgo Bioworks, which is backed by Bill Gates.
Area: Corporate, M&A
Value: $30 million
Key players: The Thomson Geer team was led by partner Emma Cook, who was supported by Belinda Pinnow and Robin Mahly.
Deal significance: Ms Cook said: “We were pleased to have been able to help Microba list on the ASX and enable investors to support its work in human health.”
The Lawyers Weekly Jobs Board has had a refresh! To check out the latest opportunities in private practice, in-house and more, click here.
Jerome Doraisamy
Jerome Doraisamy is the editor of Lawyers Weekly and HR Leader. He has worked at Momentum Media as a journalist on Lawyers Weekly since February 2018, and has served as editor since March 2022. In June 2024, he also assumed the editorship of HR Leader. Jerome is also the author of The Wellness Doctrines book series, an admitted solicitor in NSW, and a board director of the Minds Count Foundation.
You can email Jerome at:
